NCT01333020

Brief Summary

This comparative pilot study is designed to compare the rates of gastric emptying and by inference rates of digestion of two food emulsions. Two types of milk protein stabilised food emulsion will be compared, one standard emulsion preparation and one emulsion preparation cross-linked with microbial transglutaminase. The information from this study will then be compared to data on satiety and endocrine hormones from a parallel study undertaken in Finland using the same two meal formulations. The drinks will be labeled with a stable isotope of carbon and samples of breath collected every 20 minutes after consumption of the drink. This will allow gastric residence time to be calculated. The pilot will also fulfill two secondary objectives. At the same time as the breath samples are collected MRI scans of the upper abdomen will be made so that gastric volumes can be measured in order to compare the two methods of measuring gastric emptying rates. Additionally, samples of saliva will also be collected after every MRI scan for subsequent mass spectrometry analysis. These are to assess the efficacy of mass spectrometry analysis for detection of the presence of specific digestion related hormones such as ghrelin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable healthy-volunteers

Timeline
Completed

Started Nov 2010

Typical duration for not_applicable healthy-volunteers

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2010

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 11, 2011

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
Last Updated

June 22, 2012

Status Verified

June 1, 2012

Enrollment Period

1.6 years

First QC Date

April 8, 2011

Last Update Submit

June 21, 2012

Conditions

Keywords

emulsionproteincross-linkinggastric emptying

Outcome Measures

Primary Outcomes (1)

  • Rate of gastric emptying by MRI

    rate measured from MRI images of gastric contents

    20 minute intervals over 3 hours

Secondary Outcomes (2)

  • Gastric emptying by C13

    every 20 minutes over 3 hours

  • mass spectrometry detection of GI tract hormones in saliva

    every 20 minutes over 3 hours

Study Arms (1)

transglutaminase cross-linking of emulsion

EXPERIMENTAL

The impact of enzyme cross linking of the protein stabilising the test emulsion on gastric emptying rate will be assessed. In this crossover study the subjects will also consume ( on a separate day)an emulsion of the same formulation but not cross-linked.

Other: cross-linking of an emulsion drink

Interventions

This study will assess whether a subtle change in food structure (cross-linking of interfacial protein) can alter gastric emptying rate.

transglutaminase cross-linking of emulsion

Eligibility Criteria

Age20 Years - 50 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Male (hormonal status of women would introduce more variation within small group)
  • Age 20-50 years
  • BMI 19-30
  • Apparently healthy
  • Normally eat lunch
  • Willing to eat the "milkshake" style emulsion
  • Provides written informed consent

You may not qualify if:

  • You have an allergy or intolerance to rape seed oil, milk or milk proteins including lactose
  • Smokers or smoked within the last year (smoking affects satiety/hunger)
  • Diagnosed with any long term illness requiring active treatment e.g. diabetes, cancer, cardiovascular disease
  • Have had surgery on the stomach or intestine or suffered from gastrointestinal disease, whether diagnosed or self reported
  • A history of TB or hepatitis.
  • Regular (more than once in 10 days) use of antacids, laxatives
  • Diagnosis with any mouth, dental, throat or digestive problem that may affect normal eating and digestion of food.
  • Take prescription medication for digestive or gastrointestinal conditions.
  • Volunteers taking part in another study (other than a questionnaire based study).
  • Blood pressure greater than 160/100 or less than 90/50 or 95/55 if symptomatic.
  • Individuals with special dietary requirements (eg vegetarians)
  • People with eating disorders (eg. anorexia, bulimia)
  • If any of the clinical screening results are indicative of a health problem which would affect the volunteers well-being or which would affect the study data.
  • Refusal to give permission to inform GP of participation in study
  • Allergic to any of the constituents of the test meal
  • +12 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

IFR

Norwich, Norfolk, NR4 7UA, United Kingdom

Location

Study Officials

  • Alan R Mackie, PhD

    Quadram Institute Bioscience

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2011

First Posted

April 11, 2011

Study Start

November 1, 2010

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

June 22, 2012

Record last verified: 2012-06

Locations